UBS AM’s Select Medical SEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.73M | Sell |
225,710
-46,044
| -17% | -$759K | ﹤0.01% | 1750 |
|
|
2026
Q1 | $4.43M | Buy |
271,754
+12,565
| +5% | +$197K | ﹤0.01% | 1617 |
|
|
2025
Q4 | $3.85M | Sell |
259,189
-3,625
| -1% | -$51.2K | ﹤0.01% | 1592 |
|
|
2025
Q3 | $3.37M | Sell |
262,814
-184,896
| -41% | -$2.46M | ﹤0.01% | 1547 |
|
|
2025
Q2 | $6.8M | Buy |
447,710
+123,742
| +38% | +$1.93M | ﹤0.01% | 1548 |
|
|
2025
Q1 | $5.41M | Buy |
323,968
+10,329
| +3% | +$190K | ﹤0.01% | 1528 |
|
|
2024
Q4 | $5.91M | Sell |
313,639
-177,009
| -36% | -$3.41M | ﹤0.01% | 1519 |
|
|
2024
Q3 | $9.22M | Sell |
490,648
-11,200
| -2% | -$215K | ﹤0.01% | 1268 |
|
|
2024
Q2 | $9.48M | Buy |
501,848
+230,358
| +85% | +$3.93M | ﹤0.01% | 1159 |
|
|
2024
Q1 | $4.41M | Buy |
271,490
+23,983
| +10% | +$351K | ﹤0.01% | 1313 |
|
|
2023
Q4 | $3.13M | Buy |
247,507
+15,563
| +7% | +$196K | ﹤0.01% | 1468 |
|
|
2023
Q3 | $3.16M | Buy |
231,944
+17,843
| +8% | +$276K | ﹤0.01% | 1405 |
|
|
2023
Q2 | $2.98M | Hold |
214,101
| – | – | ﹤0.01% | 1464 |
|
|
2023
Q1 | $2.98M | Sell |
214,101
-3,172
| -1% | -$46.7K | ﹤0.01% | 1464 |
|
|
2022
Q4 | $2.91M | Sell |
217,273
-10,529
| -5% | -$136K | ﹤0.01% | 1367 |
|
|
2022
Q3 | $2.71M | Sell |
227,802
-36,698
| -14% | -$521K | ﹤0.01% | 1442 |
|
|
2022
Q2 | $3.37M | Buy |
264,500
+17,231
| +7% | +$221K | ﹤0.01% | 1373 |
|
|
2022
Q1 | $3.2M | Sell |
247,269
-37,607
| -13% | -$497K | ﹤0.01% | 1546 |
|
|
2021
Q4 | $4.51M | Sell |
284,876
-1,991
| -0.7% | -$34K | ﹤0.01% | 1461 |
|
|
2021
Q3 | $5.59M | Buy |
286,867
+33,131
| +13% | +$658K | ﹤0.01% | 1307 |
|
|
2021
Q2 | $5.78M | Buy |
253,736
+11,758
| +5% | +$244K | ﹤0.01% | 1305 |
|
|
2021
Q1 | $4.45M | Sell |
241,978
-9,107
| -4% | -$149K | ﹤0.01% | 1390 |
|
|
2020
Q4 | $3.74M | Sell |
251,085
-5,754
| -2% | -$75.1K | ﹤0.01% | 1411 |
|
|
2020
Q3 | $2.88M | Buy |
256,839
+6,517
| +3% | +$64.2K | ﹤0.01% | 1389 |
|
|
2020
Q2 | $1.99M | Sell |
250,322
-23,690
| -9% | -$196K | ﹤0.01% | 1518 |
|
|
2020
Q1 | $2.21M | Sell |
274,012
-24,316
| -8% | -$289K | ﹤0.01% | 1363 |
|
|
2019
Q4 | $3.75M | Buy |
298,328
+12,639
| +4% | +$136K | ﹤0.01% | 1315 |
|
|
2019
Q3 | $2.55M | Buy |
285,689
+7,634
| +3% | +$66.7K | ﹤0.01% | 1494 |
|
|
2019
Q2 | $2.38M | Buy |
278,055
+53,022
| +24% | +$419K | ﹤0.01% | 1500 |
|
|
2019
Q1 | $1.71M | Buy |
225,033
+23,535
| +12% | +$189K | ﹤0.01% | 1598 |
|
|
2018
Q4 | $1.67M | Buy |
201,498
+17,026
| +9% | +$163K | ﹤0.01% | 1514 |
|
|
2018
Q3 | $1.83M | Hold |
184,472
| – | – | ﹤0.01% | 1530 |
|
|
2018
Q2 | $1.8M | Hold |
184,472
| – | – | ﹤0.01% | 1550 |
|
|
2018
Q1 | $1.71M | Buy |
184,472
+1,855
| +1% | +$17.7K | ﹤0.01% | 1535 |
|
|
2017
Q4 | $1.74M | Buy |
182,617
+9,216
| +5% | +$88.1K | ﹤0.01% | 1498 |
|
|
2017
Q3 | $1.79M | Buy |
173,401
+6,385
| +4% | +$59K | ﹤0.01% | 1450 |
|
|
2017
Q2 | $1.38M | Sell |
167,016
-4,799
| -3% | -$36K | ﹤0.01% | 1520 |
|
|
2017
Q1 | $1.24M | Buy |
171,815
+4,640
| +3% | +$33.6K | ﹤0.01% | 1555 |
|
|
2016
Q4 | $1.19M | Sell |
167,175
-49,251
| -23% | -$343K | ﹤0.01% | 1485 |
|
|
2016
Q3 | $1.57M | Hold |
216,426
| – | – | ﹤0.01% | 1469 |
|
|
2016
Q2 | $1.27M | Buy |
216,426
+80,467
| +59% | +$533K | ﹤0.01% | 1543 |
|
|
2016
Q1 | $865K | Buy |
135,959
+6,867
| +5% | +$36.8K | ﹤0.01% | 1696 |
|
|
2015
Q4 | $829K | Buy |
129,092
+13,888
| +12% | +$86.8K | ﹤0.01% | 1814 |
|
|
2015
Q3 | $670K | Buy |
115,204
+26,122
| +29% | +$194K | ﹤0.01% | 1869 |
|
|
2015
Q2 | $778K | Buy |
89,082
+4,268
| +5% | +$35.8K | ﹤0.01% | 1808 |
|
|
2015
Q1 | $678K | Buy |
84,814
+25,984
| +44% | +$194K | ﹤0.01% | 1808 |
|
|
2014
Q4 | $456K | Buy |
58,830
+5,383
| +10% | +$39.3K | ﹤0.01% | 1995 |
|
|
2014
Q3 | $346K | Buy |
53,447
+185
| +0.3% | +$1.43K | ﹤0.01% | 2062 |
|
|
2014
Q2 | $448K | Buy |
53,262
+28,768
| +117% | +$223K | ﹤0.01% | 1955 |
|
|
2014
Q1 | $164K | Hold |
24,494
| – | – | ﹤0.01% | 2469 |
|
|
2013
Q4 | $153K | Sell |
24,494
-4,640
| -16% | -$22.7K | ﹤0.01% | 2444 |
|
|
2013
Q3 | $127K | Hold |
29,134
| – | – | ﹤0.01% | 2429 |
|
|
2013
Q2 | $129K | Buy |
+29,134
| New | +$129K | ﹤0.01% | 2360 |
|
Other funds holding SEM
GCL
AA
DAM
PAMP
UBS AM's SEM Position: Q2 2026 in Review
UBS AM reduced its Select Medical (SEM) stake by 17% in Q2 2026, selling an estimated $759K and leaving 225,710 shares worth $3.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1750.
UBS AM first reported a position in SEM in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.48M in Q2 2024. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.
- UBS AM held 225,710 shares of Select Medical worth $3.73M as of Q2 2026.
- UBS AM sold 46,044 Select Medical shares in Q2 2026, an estimated $759K.
- Select Medical made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1750 holding.
- UBS AM first reported a position in Select Medical in Q2 2013 and has held it in 53 quarters since.
- UBS AM's Select Medical position peaked at $9.48M in Q2 2024.
- 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.